Waud Capital Partners LLC’s CarePoint Partners has acquired ivA Lifetec. Financial terms were not disclosed. The deal marks CarePoint’s tenth acquisition in three years. It also marks the company’s entry into the Houston market. CarePoint provides infusion therapy services. In conjunction with the acquisition, CarePoint completed a $27 million senior debt financing with Madison Capital and Amalgamated Capital.
Waud Capital Partners (“WCP”) announced that its portfolio company, CarePoint Partners (“CarePoint”), has acquired ivA Lifetec (“Lifetec”), marking its 10th acquisition in three years and making CarePoint one of the largest and most acquisitive independent infusion therapy providers in the United States. Terms of the transaction are not being disclosed.
Based in Houston, Lifetec maintains a strong market presence throughout the Houston metropolitan area, the sixth-largest addressable market in the United States. The company provides a range of home infusion therapies including antibiotics, IVIG and nutrition and will continue to operate under the “Lifetec” name, maintaining the same team of infusion professionals that have been integral to Lifetec’s success to date.
“CarePoint is excited to enter the Houston market, which represents an important step toward our goal of providing high-quality infusion therapy services in Texas state-wide,” said Dana Soper, CarePoint’s Chief Executive Officer. “We now serve the two largest markets in Texas, covering approximately half of the state’s population.”
John Gee, co-founder of Lifetec, said, “We are very excited to team up with CarePoint Partners. Its reputation for providing high-quality patient care is well-known, and we feel our values closely align with those at CarePoint.”
In conjunction with the acquisition, CarePoint completed a $27 million senior debt financing with Madison Capital (“Madison”) and Amalgamated Capital (“AmalCap”). In addition to a traditional revolving credit facility and term loan, CarePoint now has a committed acquisition line of credit to support its growth initiatives. Madison acted as the administrative agent on the facilities, with both banks serving as co-lead arrangers.
Commenting on the financing, Dana Soper offered, “We are excited to begin new relationships with Madison and AmalCap, who will help provide CarePoint with the flexibility to grow both organically and through acquisition.”
Matt Clary, Partner at WCP, added, “We are happy to bring Lifetec into the CarePoint network and expand our presence in Texas. Additionally we are thrilled to have two lending partners who are committed to supporting CarePoint’s growth strategy.”
About CarePoint Partners
WCP teamed with Chief Executive Officer Dana Soper in 2007 to form CarePoint Partners to acquire, develop and operate a network of home infusion and specialty pharmacies. Based in Cincinnati, CarePoint provides home infusion therapy and specialty pharmacy services via 17 sites of operation in eight states. Infusion pharmacy therapy involves the administration of medications and nutrients using intravenous, subcutaneous and epidural methods. Home infusion therapy allows patients to receive these medications without the inconvenience or cost of a hospital visit.
For additional information on CarePoint, visit the company’s website at www.carepointpartners.com
About Waud Capital Partners
WCP is a leading middle market private equity investment firm founded in 1993 that partners with exceptional management teams to invest in growth equity investments, industry consolidations, buyouts and recapitalizations. The firm seeks to invest $10 million to $100 million in private companies in the following four areas: healthcare services, business and consumer services, specialty distribution and value-added industrial businesses. Typically, the companies in which WCP invests have enterprise values between $30 million and $300 million.
For additional information on WCP, visit the firm’s website at www.waudcapital.com
For Further Information:
Matt Clary, Partner
Waud Capital Partners
Dana Soper, Chief Executive Officer
For Media Inquiries:
Jen Dowd, Director